1966
DOI: 10.1136/bmj.1.5479.80
|View full text |Cite
|
Sign up to set email alerts
|

Further experience with indomethacin in the treatment of rheumatic disorders.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0
1

Year Published

1968
1968
2018
2018

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 41 publications
(18 citation statements)
references
References 4 publications
0
17
0
1
Order By: Relevance
“…The present study describes the designing and synthesis of a small molecule, tryptamine-gallic acid hybrid (SEGA (3a)), which prevents NSAID-induced mitochondrial pathology, apoptosis, and gastropathy by blocking MOS through scavenging of intramitochondrial O 2 . and free iron and correcting mitochondrial dysfunction.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…The present study describes the designing and synthesis of a small molecule, tryptamine-gallic acid hybrid (SEGA (3a)), which prevents NSAID-induced mitochondrial pathology, apoptosis, and gastropathy by blocking MOS through scavenging of intramitochondrial O 2 . and free iron and correcting mitochondrial dysfunction.…”
Section: Discussionmentioning
confidence: 99%
“…2 are the most popular drugs commonly used throughout the world for the treatment of pain, inflammation, rheumatic disorders, and osteoarthritis (1,2). Approximately 30 million patients consume NSAIDs on a daily basis (1).…”
Section: Nsaidsmentioning
confidence: 99%
See 2 more Smart Citations
“…İndometazin durdurulduğu andan itibaren üç aylık periyodda halüsinasyonlar görülmemiştir. 44 Bir olgu bildiriminde, paranoit delüzyonlar ve halüsinasyonlar geliştiren 58 yaşındaki bir erkek hastanın indometazin aldığı bildirilmiştir. Ayrıca, bu etkiler sadece gece uyanma sırasında gerçekleşmiştir.…”
Section: İndometazi̇nunclassified